AM424: History of a novel drug candidate

Clinical and Experimental Pharmacology and Physiology

Volumn 27, Issue 7, 2000, Pages 553-557

  Kurek, John ^a  

^a Zenyth Therapeutics Limited Australia   (Australia)

Author keywords

AM424; Leukaemia inhibitory factor; Muscle; Nerve; Peripheral neuropathy; Regeneration

Indexed keywords

AM 424; CARDIOTROPHIN 1; CILIARY NEUROTROPHIC FACTOR; CYTOKINE; GLYCOPROTEIN GP 130; INTERLEUKIN 11; INTERLEUKIN 6; LEUKEMIA INHIBITORY FACTOR; NEW DRUG; ONCOSTATIN M; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MECHANISM; HUMAN; MOTONEURON; MOTOR NEURON DISEASE; MOUSE; MUSCLE ATROPHY; MUSCLE REGENERATION; NERVE FIBER TRANSECTION; NERVE INJURY; NEUROMUSCULAR FUNCTION; NONHUMAN; PERIPHERAL NEUROPATHY; PHASE 1 CLINICAL TRIAL; SENSORY NERVE CELL; SIGNAL TRANSDUCTION;

ANIMALS; CELL SURVIVAL; GROWTH INHIBITORS; HUMANS; INTERLEUKIN-6; LEUKEMIA INHIBITORY FACTOR; LYMPHOKINES; MICE; NERVE DEGENERATION; NEUROMUSCULAR AGENTS; NEURONS; RECOMBINANT PROTEINS;

EID: 0034125226     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1681.2000.03289.x     Document Type: Conference Paper

References (38)

1. 1. Hilton DJ. LIF. Lots of interesting functions. Trends Biochem. Sci. 1992; 17: 72-6.
2. 2. Willson TA, Metcalf D, Gough NM. Cross-species comparison of the sequence of the leukaemia inhibitory factor gene and its protein. Eur. J. Biochem. 1992; 204: 21-30.
3. 3. Gearing DP, Comeau MR, Friend DJ et al. The IL-6 signal transducer, gp130: An ancostatin M receptor and affinity converter for the LIF receptor. Science 1992; 255: 1433-7.
4. 4. Hirano T, Matsuda T, Nakajima K. Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokine subfamily. Stem Cells 1994; 12: 262-77.
5. 5. Gearing DP, VandenBos T, Beckmann MP et al. Reconstitution of high affinity leukaemia inhibitory factor (LIF) receptors in haemopoietic cells transfected with the cloned human LIF receptor. Ciba Found. Symp. 1992; 167: 245-59.
6. 6. Gearing DP, Ziegler SF, Comeau MR et al. Proliferative responses and binding properties of hematopoietic cells transfected with low-affinity receptors for leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor. Proc. Natl Acad. Sci. USA 1994; 91: 1119-23.
7. 7. Hilton DJ, Nicola NA, Metcalf D. Distribution and binding properties of receptors for leukaemia inhibitory factor. Ciba Found. Symp. 1992; 167: 227-44.
8. 8. Davis S, Aldrich TH, Stahl SC et al. LIFR beta and gp130 as hetero-dimerizing signal transducers of the tripartite CNTF receptor. Science 1993; 260: 1805-8.
9. 9. Waring PM. Leukemia inhibitory factor. In: Garland J, Quesenberry P, Hilton D (eds). Colony Stimulating Factors: Molecular and Cellular Biology. Marcel Dekker Inc., New York. 1997; Ch. 21.
10. 10. Boulton TG, Stahl N, Yancopoulos GD. Ciliary neurotrophic factor/leukemia inhibitory factor/interleukin 6/oncostatin M family of cytokines induces tyrosine phosphorylation of a common set of proteins overlapping those induced by other cytokines and growth factors. J. Biol. Chem. 1994; 269: 11 648-55.
11. 11. Bower JJ, Vakakis N, Nicola NA, Austin L. Specific binding of leukemia inhibitory factor to murine myoblasts in culture. J. Cell. Physiol. 1995; 164: 93-8.
12. 12. Stahl N, Boulton TG, FarrugellaT et al. Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. Science 1994; 263: 92-5.
13. 13. Hendry IA, Murphy M, Hilton DJ, Nicola NA, Bartlett PF. Binding and retrograde transport of leukemia inhibitory factor by the sensory nervous system. J. Neurosci. 1992; 12: 3427-34.
14. 14. Curtis R, Scherer SS, Somogyi R et al. Retrograde axonal transport of LIF is increased by peripheral nerve injury: Correlation with increased LIF expression in distal nerve. Neuron 1994; 12: 191-204.
15. 15. Thompson SW, Vernallis AB, Heath JK, Priestley J. Leukaemia inhibitory factor is retrogradely transported by a distinct population of adult rat sensory neurons: Co-localization with trkA and other neurochemical markers. Eur. J. Neurosci. 1997; 9: 1244-51.
16. 16. Bennett T, Dowsing B, Austin L, Messina A, Nicola N, Morrison W. Anterograde transport of leukaemia inhibitory factor (LIF) within axotomised sciatic nerves. Muscle Nerve 1999; 22: 78-87.
17. 17. Zigmond RE, Hyatt-Sachs H, Mohney RP et al. Changes in neuropeptide phenotype after axotomy of adult peripheral neurons and the role of leukemia inhibitory factor. Perspect. Dev. Neurobiol. 1996; 4: 75-90.
18. 18. Verge VM, Richardson PM, Wiesenfeld-Hallin Z, Hokfelt T. Differential influence of nerve growth factor on neuropeptide expression in vivo: A novel role in peptide suppression in adult sensory neurons. J. Neurosci. 1995; 15: 2081-96.
19. 19. Shadiack AM, Vaccariello SA, Sun Y, Zigmond RE. Nerve growth factor inhibits sympathetic neurons' response to an injury cytokine. Proc. Natl Acad. Sci. USA 1998; 95: 7727-30.
20. 20. Banner LR, Patterson PH. Major changes in the expression of the mRNAs for cholinergic differentiation factor/leukemia inhibitory factor and its receptor after injury to adult peripheral nerves and ganglia. Proc. Natl Acad. Sci. USA 1994; 91: 7109-13.
21. 21. Sun Y, Rao MS, Zigmond RE, Landis SC. Regulation of vasoactive intestinal peptide expression in sympathetic neurons in culture and after axotomy: The role of cholinergic differentiation factor/leukemia inhibitory factor. J. Neurobiol 1995; 25: 415-30.
22. 22. Sun Y, Zigmond RE. Involvement of leukemia inhibitory factor in the increases in galanin and vasoactive intestinal peptide mRNA and the decreases in neuropeptide Y and tyrosine hydroxylase mRNA in sympathetic neurons after axotomy. J. Neurochem. 1996; 67: 1751-60.
23. 23. Sun Y, Zigmond RE. Leukaemia inhibitory factor induced in the sciatic nerve after axotomy is involved in the induction of galanin in sensory neurons. Eur. J. Neurosci. 1996; 8: 2213-20.
24. 24. Zigmond RE, Sun Y. Regulation of neuropeptide expression in sympathetic neurons. Paracrine and retrograde influences. Ann. NY Acad. Sci. 1997; 814: 181-97.
25. 25. Cheema SS, Richards L, Murphy M, Bartlett PF. Leukaemia inhibitory factor rescues motoneurones from axotomy-induced cell death. Neuroreport 1994; 5: 989-92.
26. 26. Cheema SS, Richards L, Murphy M, Bartlett PF. Leukemia inhibitory factor prevents the death of axotomised sensory neurons in the dorsal root ganglia of the neonatal rat. J. Neurosci. Res. 1994; 37: 213-18.
27. 27. Ikeda K, Iwasaki Y, Shiojima T, Kinoshita M. Neuroprotective effect of various cytokines on developing spinal motoneurons following axotomy. J. Neurol. Sci. 1996; 135: 109-13.
28. 28. Finkelstein DI, Bartlett PF, Horne MK, Cheema SS. Leukemia inhibitory factor is a myotrophic and neurotrophic agent that enhances the reinnervation of muscle in the rat. J. Neurosci. Res. 1996; 46: 122-8.
29. 29. Donato R, Cheema SS, Finkelstein D, Bartlett PF, Morrison W. Role of leukaemia inhibitory factor (LIF) in rat peripheral nerve regeneration. Ann. Acad. Med. Singapore 1995; 24 (Suppl. 4): 94-100.
30. 30. Tham S, Dowsing B, Finkelstein D et al. Leukemia inhibitory factor enhances the regeneration of transected rat sciatic nerve and the function of reinnervated muscle. J. Neurosci. Res. 1997; 47: 208-15.
31. 31. Ikeda K, Iwasaki Y, Shiojima T, Kinoshita M. Neuroprotective effect of cholinergic differentiation factor/Leukemia inhibitory factor on wobbler motor neurone disease. Muscle Nerve 1995; 18: 1344-7.
32. 32. Austin L, Burgess AW. Stimulation of myoblast proliferation inculture by leukaemia inhibitory factor and other cytokines. J. Neurol. Sci. 1991; 101: 193-7.
33. 33. Austin L, Bower J, Kurek J, Vakakis N. Effects of leukaemia inhibitory factor and other cytokines on murine and human myoblast proliferation. J. Neurol. Sci. 1992; 112: 185-91.
34. 34. Vakakis N, Bower J, Austin L. In vitro myoblast to myotube transformations in the presence of leukemia inhibitory factor. Neurochem. Int. 1995; 27: 329-35.
35. 35. Kurek JB, Bower JJ, Romanella M, Kontgen F, Murphy M, Austin L. The role of leukaemia inhibitory factor in skeletal muscle regeneration. Muscle Nerve 1997; 20: 815-22.
36. 36. Barnard W, Bower J, Brown M, Murphy M, Austin L. Leukemia inhibitory factor (LIF) infusion stimulates skeletal muscle regeneration after injury: Injured muscle expresses LIF mRNA. J. Neurol. Sci. 1994; 123: 108-13.
37. 37. Kurek JB, Bower JJ, Romanella M, Austin L. Leukaemia inhibitory factor treatment stimulates muscle regeneration in the mdx mouse. Neurosci. Lett. 1996; 212: 167-70.
38. 38. Bower J, White JD, Kurek JB, Muldoon CM, Austin L. The role of growth factors in myoblast transfer therapy. Basic Appl. Myol. 1997; 7: 177-86.